Central Trust Company’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-11
Closed 1332
2022
Q3
$0 Hold
11
﹤0.01% 1414
2022
Q2
$0 Sell
11
-260
-96% -$11K ﹤0.01% 1454
2022
Q1
$20K Sell
271
-118
-30% -$8.5K ﹤0.01% 955
2021
Q4
$36K Buy
389
+11
+3% +$1.31K ﹤0.01% 850
2021
Q3
$48K Hold
378
﹤0.01% 772
2021
Q2
$63K Sell
378
-25
-6% -$4.05K ﹤0.01% 702
2021
Q1
$74K Hold
403
﹤0.01% 651
2020
Q4
$81K Buy
403
+25
+7% +$5.08K ﹤0.01% 624
2020
Q3
$83K Hold
378
﹤0.01% 584
2020
Q2
$72K Hold
378
﹤0.01% 576
2020
Q1
$59K Hold
378
﹤0.01% 587
2019
Q4
$32K Hold
378
﹤0.01% 752
2019
Q3
$26K Hold
378
﹤0.01% 755
2019
Q2
$27K Buy
378
+171
+83% +$9.97K ﹤0.01% 751
2019
Q1
$12K Sell
207
-100
-33% -$6.11K ﹤0.01% 852
2018
Q4
$15K Buy
307
+207
+207% +$12.7K ﹤0.01% 819
2018
Q3
$9K Buy
+100
New +$7.13K ﹤0.01% 1043

Other funds holding TDOC

Central Trust Company's TDOC Position: Q4 2022 in Review

Central Trust Company sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 11 shares.

Central Trust Company first reported a position in TDOC in Q3 2018 and held it in 17 quarters. The position peaked at $83K in Q3 2020. 443 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Central Trust Company reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Central Trust Company sold 11 Teladoc Health shares in Q4 2022.
  • Central Trust Company first reported a position in Teladoc Health in Q3 2018 and held it in 17 quarters.
  • Central Trust Company's Teladoc Health position peaked at $83K in Q3 2020.
  • 443 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Central Trust Company's 13F filing for Q4 2022, filed 26 Jan 2023.